HomeCompareCITAY vs JNJ

CITAY vs JNJ: Dividend Comparison 2026

CITAY yields 3.59% · JNJ yields 2.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CITAY wins by $1020.25M in total portfolio value
10 years
CITAY
CITAY
● Live price
3.59%
Share price
$7.00
Annual div
$0.25
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1020.28M
Annual income
$968,411,466.34
Full CITAY calculator →
JNJ
Johnson & Johnson
● Live price
2.13%
Share price
$244.44
Annual div
$5.20
5Y div CAGR
28%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.3K
Annual income
$4,689.40
Full JNJ calculator →

Portfolio growth — CITAY vs JNJ

📍 CITAY pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCITAYJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CITAY + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CITAY pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CITAY
Annual income on $10K today (after 15% tax)
$304.87/yr
After 10yr DRIP, annual income (after tax)
$823,149,746.39/yr
JNJ
Annual income on $10K today (after 15% tax)
$180.82/yr
After 10yr DRIP, annual income (after tax)
$3,985.99/yr
At 15% tax rate, CITAY beats the other by $823,145,760.40/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CITAY + JNJ for your $10,000?

CITAY: 50%JNJ: 50%
100% JNJ50/50100% CITAY
Portfolio after 10yr
$510.15M
Annual income
$484,208,077.87/yr
Blended yield
94.91%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

CITAY
No analyst data
Altman Z
0.3
Piotroski
7/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
-6.4% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CITAY buys
0
JNJ buys
0
No recent congressional trades found for CITAY or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCITAYJNJ
Forward yield3.59%2.13%
Annual dividend / share$0.25$5.20
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%28%
Portfolio after 10y$1020.28M$30.3K
Annual income after 10y$968,411,466.34$4,689.40
Total dividends collected$1016.53M$15.4K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CITAY vs JNJ ($10,000, DRIP)

YearCITAY PortfolioCITAY Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,417$717.34$10,592$272.30+$825.00CITAY
2$13,747$1,530.87$11,289$357.73+$2.5KCITAY
3$18,155$3,445.41$12,123$472.89+$6.0KCITAY
4$27,931$8,504.82$13,141$629.86+$14.8KCITAY
5$54,343$24,456.57$14,408$846.81+$39.9KCITAY
6$147,087$88,940.19$16,021$1,151.60+$131.1KCITAY
7$607,347$449,963.84$18,122$1,588.22+$589.2KCITAY
8$4,122,718$3,472,857.35$20,930$2,228.20+$4.10MCITAY
9$48,474,929$44,063,620.61$24,792$3,191.91+$48.45MCITAY
10$1,020,279,641$968,411,466.34$30,274$4,689.40+$1020.25MCITAY

CITAY vs JNJ: Complete Analysis 2026

CITAYStock

COSCO SHIPPING Development Co., Ltd., together with its subsidiaries, provides vessel chartering and container leasing services. It operates through Shipping and Industry-Related Leasing, Container Manufacturing, and Investment and Financial Services segments. The company manufactures and sells containers; and offers operating leasing, equity or debt investment, and insurance brokerage, as well as financial leasing services in the areas of health care, education, energy, construction, and industrial communication. As of December 31, 2021, it had 74 container ships. The company was formerly known as China Shipping Container Lines Company Limited and changed its name to COSCO SHIPPING Development Co., Ltd. in December 2016. COSCO SHIPPING Development Co., Ltd. was founded in 1997 and is headquartered in Shanghai, the People's Republic of China.

Full CITAY Calculator →

JNJHealthcare

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.

Full JNJ Calculator →
📬

Get this CITAY vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CITAY vs SCHDCITAY vs JEPICITAY vs OCITAY vs KOCITAY vs MAINCITAY vs ABBVCITAY vs MRKCITAY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.